Literature DB >> 15013855

Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure.

Che Fang1, Seokjoo Yoon, Niclas Tindberg, Harri A Järveläinen, Kai O Lindros, Magnus Ingelman-Sundberg.   

Abstract

Acute systemic lipopolysaccharide (endotoxin, LPS) exposure, which can lead to septic shock, enhances the hepatic expression of inflammatory and acute-phase proteins (APPs). To better understand how LPS aggravates damage, changes in hepatic gene expression after a single LPS dose was screened by using microarrays for 1176 rat genes. We detected more than 20 new potential LPS-induced APPs. Following acute LPS challenge, significant up-regulation of the steady-state mRNA levels of several important early transcription factors, such as c-jun and STAT3, and cytokine-associated genes, was observed. In contrast, RT-PCR analysis revealed marked down-regulation of the nuclear receptors RXRalpha, PXR, FXR, LXR, PPARalpha and CAR. Also genes encoding lipolytic, antioxidant as well as drug- and alcohol-metabolizing enzymes were down-regulated. These data suggest that acute LPS treatment induces important early transcription factors and co-ordinately down-regulates nuclear receptors, and that this results in altered expression of a large number of downstream genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013855     DOI: 10.1016/j.bcp.2003.12.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  18 in total

1.  Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway.

Authors:  Shogo Takahashi; Naoki Tanaka; Srujana Golla; Tatsuki Fukami; Kristopher W Krausz; Marianne A Polunas; Blair C Weig; Yusuke Masuo; Cen Xie; Changtao Jiang; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2017-08-01       Impact factor: 4.849

2.  Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s.

Authors:  Charles S Venuto; Jihoon Lim; Susan Messing; Peter W Hunt; Grace A McComsey; Gene D Morse
Journal:  Antivir Ther       Date:  2018

3.  Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain.

Authors:  Denis Projean; Sophie Dautrey; Huy Khan Vu; Thierry Groblewski; Jean-Louis Brazier; Julie Ducharme
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

Review 4.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

5.  Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.

Authors:  Albert Lee; Joel M Chick; Daniel Kolarich; Paul A Haynes; Graham R Robertson; Maria Tsoli; Lucy Jankova; Stephen J Clarke; Nicolle H Packer; Mark S Baker
Journal:  Mol Cell Proteomics       Date:  2010-02-18       Impact factor: 5.911

6.  Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures.

Authors:  Choon-Myung Lee; Jan Pohl; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

7.  Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid.

Authors:  Romi Ghose; Tao Guo; Nadia Haque
Journal:  Arch Biochem Biophys       Date:  2008-10-08       Impact factor: 4.013

Review 8.  Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression.

Authors:  Satyanarayana R Pondugula; Hanqing Dong; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-08       Impact factor: 4.481

9.  Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.

Authors:  Sylvie M Mimche; Beatrice A Nyagode; Matthew D Merrell; Choon-Myung Lee; Nina S Prasanphanich; Richard D Cummings; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-10-25       Impact factor: 3.922

10.  Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells.

Authors:  Guat-Siew Chew; Stephen Myers; Alexander Chong Shu-Chien; Tengku Sifzizul Tengku Muhammad
Journal:  Mol Cell Biochem       Date:  2013-11-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.